INS and type 1 diabetes mellitus: Similarly, increased site-specific cancer risks among individuals with type 1 and 2 diabetes, though showing a smaller excess risk for type 1 diabetes, suggest that a common diabetes-related determinant other than insulin use affects the cancer incidence [5].